Nuvectra Corporation announced that it has received full-body MR-conditional approval for the company's Algovita SCS system from its European Notified Body, T V S D. The approval closely follows the company's announcement regarding its receipt of head-only MR-conditional approval for Algovita from the U.S. Food and Drug Administration (FDA).